News

November 23, 2009 — SNM will hold its Conjoint Mid-Winter Meetings on Jan. 27-Feb. 2, 2010, at the Albuquerque Convention Center in Albuquerque, N.M.

Home December 01, 2009
Home
News

November 17, 2009 — The recent discovery of 3,500-year-old Egyptian mummies showing signs of hardening of the arteries indicates that heart disease is not just a condition found in modern humans as commonly believed.

Home December 01, 2009
Home
News

November 18, 2009 — Results of preclinical studies with CXL-1020 demonstrate beneficial effects across the board on the treatment of acute decompensated heart failure (ADHF). All three major facets of the pathophysiology — contractability, relaxation and vascular load — showed improvements with no significant safety liabilities.

Home December 01, 2009
Home
News

November 21, 2009 – The first randomized intracardiac arrest cooling study performed using a intra-nasal cooling method showed promising results. Findings included much faster and earlier cooling in treated patients and significantly higher neurologically intact survival to discharge rate in many patients.

Home December 01, 2009
Home
News

November 21, 2009 — A drug used to treat erectile dysfunction may improve heart function in children and young adults with single ventricle congenital heart disease, according to researchers from The Children’s Hospital of Philadelphia.

Home December 01, 2009
Home
News

November 21, 2009 – The Food and Drug Administration (FDA) recently announced that it is reviewing data from a study suggesting patients using the drug sibutramine may have a higher number of cardiovascular events than patients using a placebo.

Home December 01, 2009
Home
Technology

November 29, 2009 - A new advanced visualization and decision support software upgrade is designed to improve management of CT stroke protocols and 3D or 2D viewing. It also provides electronic medical record (EMR) integration.

Home November 28, 2009
Home
News

November 24, 2009 - Seventy million dollars in grant money will go to community college training programs for health information technology professionals, and $10 million is designated to develop educational materials to support these programs.

Home November 24, 2009
Home
News

November 24, 2009 – European CE mark clearance was granted this week for BridgePoint Medical’s coronary and peripheral chronic total occlusion (CTO) crossing system comprised of the CrossBoss CTO Crossing Catheter and the Stingray CTO Re-Entry System.

Home November 24, 2009
Home
Technology

November 24, 2009 - The academic and research communities can access free 2D/3D Windows-based software for reviewing imaging data from CT, MR, PET, ultrasound and X-ray.

Home November 24, 2009
Home
Technology

November 24, 2009 – New imaging client-server technology is designed to create efficiency and ease of use from any location. With an unlimited number of installed clients, there can be 3/10/20 concurrent users, depending on server hardware configuration and system load.

Home November 23, 2009
Home
Technology

November 23, 2009 – Using less lytic drug and offering faster clot dissolution than traditional deep vein thrombosis (DVT) treatments, EKOS Corp. launched the EkoSonic MACH4e at the recent VEITH Symposium in New York.

Home November 23, 2009
Home
Technology

November 23, 2009 – The U.S. Food and Drug Administration (FDA) Nov. 20 approved Revatio (sildenafil) Injection, an intravenous formulation of Revatio, for the treatment of adult patients with pulmonary arterial hypertension (WHO Group I) to improve exercise ability and delay clinical worsening.

Home November 23, 2009
Home
News

November 21, 2009 – Endovascular repair of a ruptured abdominal aortic aneurysm (EVAR) is superior to open repair, according to a study data released Nov. 18-22 at the VEITH Symposium in New York. The study found EVAR is best in patients with favorable anatomy and in centers that have access to vascular surgeons.

Home November 23, 2009
Home
News

November 18, 2009 — A new, reversible blood thinner did not prove superior over placebo for its primary endpoints of heart attack and need for revascularization, but it did reduce in-stent blood clots. Researchers reported the findings in a late-breaking clinical trial presentation at the American Heart Association’s Scientific Sessions this week.

Home November 20, 2009
Home
Subscribe Now